Sorrento Gets Green Light To Delay $21M Ch. 11 Sale
Drug developer Sorrento Therapeutics can push the close of its $20.9 million asset sale from Thursday to April 1, a Texas bankruptcy judge ruled Tuesday, after attorneys for the debtor said...To view the full article, register now.
Already a subscriber? Click here to view full article